Literature DB >> 483252

The effect of venous occlusion on antithrombin III, plasminogen activator and fibrinogen degradation product (fragment E) levels.

T K Chan, V Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 483252     DOI： 10.1016/0049-3848(79)90108-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  Antithrombin III in patients on long-term oral anticoagulants.

Authors:  H Bull; I Mackie; M Brozović; D Woodings
Journal:  J Clin Pathol       Date:  1980-12       Impact factor: 3.411

2.  Antithrombin III and fibrinogen degradation product (fragment E) in diabetic nephropathy.

Authors:  V Chan; C K Yeung; T K Chan
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

3.  Abnormal endothelial release of fibrinolytic activity and fibronectin in diabetic microangiopathy.

Authors:  B Haitas; A J Barnes; S A Cederholm-Williams; J Moore; M E Shogry; R C Turner
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

4.  Effects of Preoperative Glycyrrhizin Infusion for the Prevention of Venous Thrombosis on the Tissue Expression of Antithrombin in a Rat Model.

Authors:  Nobuaki Nakata; Yukimi Kira
Journal:  Ann Vasc Dis       Date:  2016-04-26

5.  "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. I. Normal values, application in thrombocytopenic patients and evaluation of heparin and aspirin effects.

Authors:  H Janzarik; S Remy; S Morell; W Pabst
Journal:  Blut       Date:  1986-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.